Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Ambu

68.05 DKK-2.72 %4.9, 17.10
Less than 1K followers

AMBU B

NASDAQ Copenhagen

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor views
Compare
-2.72 %
-7.41 %
+6.41 %
-8.78 %
-22.67 %
-28.86 %
-18.56 %
-67.66 %
+6,970.13 %

Ambu is active in medical technology. The company develops and markets diagnostic equipment for actors in healthcare. The largest activity is found in the development of solutions for endoscopy, gastroscopy and patient monitoring. Operations are held on a global level with the largest presence in Europe and North America. Ambu was founded in 1937 and is headquartered in Ballerup, Denmark.

Read more
Market cap
18.33B DKK
Turnover
85.97M DKK
Revenue
6.04B
EBIT %
12.99 %
P/E
29.72
Dividend yield-%
0.6 %
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Research
Press releases
ShowingAll content types

Forum discussions
Today, the Q4 interim report for FY2019/20 was released. The endoscope business grew by 81% and accounted for 48% of the company’s revenue during the fiscal year. Growth is expected to continue at a good level. In terms of units, 1.085 million endoscopes were sold, and sales of 1...
11/11/2020, 9:39 AM
by Mikko Kiesiläinen
4
However, even this company made its biggest profit ever in 2025 (it probably increased by about 2.5 times from 2024), and revenue is growing very predictably (year after year). I think the decline experienced in the stock is just a correction of the high valuation of previous years...
3/20/2026, 7:21 AM
3
Since the thread has been dead for years, I dare to ask silly questions even with shaky knowledge. Has anyone more knowledgeable followed the endoscopy market in recent years? What does the competitive situation look like now that healthcare has returned to normal times? When I looked...
3/19/2026, 1:11 PM
by Zoltan
3
The markets didn’t like it; down nearly -5% today. Revenue growth slowed and operating profit decreased—pretty sluggish figures. I considered buying several times, but luckily I didn’t hit the buy button. Their performance isn’t convincing when, according to them, there should be...
5/6/2026, 2:19 PM
by Zoltan
2
Salkunrakentaja has an article about this: SalkunRakentaja – 21 Aug 21 Tanskalainen Ambu kasvaa vauhdilla uusien tuotteiden siivittämänä Sairaaloiden ja pelastuslaitosten laitevalmistaja Ambu saa Handelsbankenilta ostosuosituksen. Yhtiöön kohdistuu kovat kasvuodotukset. The article...
8/22/2021, 6:04 AM
by Ruudolf
1
Q3 was released a few days ago: Investor Relations Still seems expensive. Growth has stumbled a bit this year. It would be interesting to know more precisely why, and whether the problems are temporary.
8/22/2021, 4:09 AM
by Taavetti
1
Ambu’s results will be out tomorrow. The valuation level is certainly dizzying. With the numbers for the 2021E financial year ending in September, the EV/EBITDA is 89.4x. If there is a disappointment tomorrow, the drop could be significant.
1/26/2021, 8:37 AM
by Mikko Kiesiläinen
1
Read more on our forum
Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
5.11
2026

Annual report '26

2.12
2026

General meeting '26

Regulatory press release31.08.2026, 11.23

TRANSACTIONS UNDER AMBU’S SHARE BUYBACK PROGRAM

Ambu
HCA Morgenbørs 28/08 - Freetrailer CEO-interview og positiv rebound fra morgenstunden i Europa
Video28.08.2026, 10.07 by
Rasmus Køjborg, Jacob Frehr

HCA Morgenbørs 28/08 - Freetrailer CEO-interview og positiv rebound fra morgenstunden i Europa

Udsigt til en positiv rebound fra morgenstunden i Europa. Fokus på regnskaber fra Hafnia, NNIT og HusCompagniet. Gæst i studiet her til morgen er CEO Thomas Zeihlund fra Freetrailer.

HafniaFreetrailer GroupMT Højgaard HoldingInstallatørGruppenDanske BankNovo NordiskBooztRockwoolNNITAmbuTormGreenMobilityBang & OlufsenHusCompagniet
HCA Morgenbørs 27/08 - Fokus på Nvidia og Interview med Søren Truelsen fra Nordic Bloom
Video27.08.2026, 10.41 by
Michael Friis, Jacob Frehr

HCA Morgenbørs 27/08 - Fokus på Nvidia og Interview med Søren Truelsen fra Nordic Bloom

Udsigt til positiv åbning i Europa her til morgen efter Nvidia leverede. Vi ser ind på reaktioner ovenpå gårsdagens danske regnskabsbyge. Gæst i studiet her til morgen er Søren Truelsen, Nordic Bloom for at se ind i den kommende US IPO bølge.

NvidiaAmbuNovo NordiskAL SydbankVestas Wind SystemsTormInstallatørGruppenPandoraDanske BankNorth MediaRTXScandinavian Tobacco GroupMT Højgaard HoldingPer Aarsleff HoldingCurasight

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
HCA Morgenbørs 26/08 - GomSpace CEO-interview og fokus på regnskaber fra bl.a. TORM, AL Sydbank og Ambu
Video26.08.2026, 10.07 by
Rasmus Køjborg, Victor Skriver

HCA Morgenbørs 26/08 - GomSpace CEO-interview og fokus på regnskaber fra bl.a. TORM, AL Sydbank og Ambu

Udsigt til positiv åbning i Europa her til morgen. Fokus på regnskaber fra bl.a. TORM, AL Sydbank og Ambu. Gæst i studiet her til morgen er CEO Carsten Drachmann fra GomSpace.

GomSpaceAmbuAL SydbankPer Aarsleff HoldingInstallatørGruppenGubraGabriel HoldingTorm
Analyst Comment25.08.2026, 18.37

HCA Red Flag: Ambu lowers its growth outlook for the second time (AI)

The share should be able to hold its level: Endoscopy Solutions grew by 16.0% vs. the expected 15.5%, and the margin outlook moves to the upper end of the range. The downside is a growth outlook that is downgraded for the second time this year, and an earnings result 9% below expectations.

Ambu
Regulatory press release25.08.2026, 18.01

INTERIM REPORT FOR Q3

Ambu
Regulatory press release25.08.2026, 18.00

AMBU UPDATES FINANCIAL OUTLOOK FOR 2025/26

Ambu
Regulatory press release24.08.2026, 14.03

TRANSACTIONS UNDER AMBU’S SHARE BUYBACK PROGRAM

Ambu
Regulatory press release17.08.2026, 12.49

TRANSACTIONS UNDER AMBU’S SHARE BUYBACK PROGRAM

Ambu
Regulatory press release10.08.2026, 11.14

TRANSACTIONS UNDER AMBU’S SHARE BUYBACK PROGRAM

Ambu
Regulatory press release03.08.2026, 11.32

TRANSACTIONS UNDER AMBU’S SHARE BUYBACK PROGRAM

Ambu
Regulatory press release27.07.2026, 12.15

TRANSACTIONS UNDER AMBU’S SHARE BUYBACK PROGRAM

Ambu
Regulatory press release20.07.2026, 12.12

TRANSACTIONS UNDER AMBU’S SHARE BUYBACK PROGRAM

Ambu
Regulatory press release13.07.2026, 17.12

TRANSACTIONS UNDER AMBU’S SHARE BUYBACK PROGRAM

Ambu
Regulatory press release06.07.2026, 15.30

TRANSACTIONS UNDER AMBU’S SHARE BUYBACK PROGRAM

Ambu
Regulatory press release29.06.2026, 09.40

TRANSACTIONS UNDER AMBU’S SHARE BUYBACK PROGRAM

Ambu
Regulatory press release22.06.2026, 09.19

TRANSACTIONS UNDER AMBU’S SHARE BUYBACK PROGRAM

Ambu
Regulatory press release15.06.2026, 10.17

TRANSACTIONS UNDER AMBU’S SHARE BUYBACK PROGRAM

Ambu
Regulatory press release09.06.2026, 09.35

REPORTING OF TRANSACTIONS MADE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

Ambu
Regulatory press release08.06.2026, 11.36

TRANSACTIONS UNDER AMBU’S SHARE BUYBACK PROGRAM

Ambu